Sebaceous hyperplasia manifests as small, yellowish, dome-shaped papules, typically ranging from 2 to 4 millimeters in diameter. These lesions are not a form of acne, nor are they infectious; they represent a benign overgrowth of sebaceous glands. While medically harmless, their tendency to appear on highly visible areas like the forehead, cheeks, and nose often makes treatment a primary concern for those seeking to maintain a smooth skin texture. As of 2026, the landscape of sebaceous hyperplasia treatment has expanded from traditional destructive methods to highly targeted energy-based therapies that minimize the risk of scarring and recurrence.

Identifying the Lesion Before Seeking Treatment

Successful treatment begins with a precise diagnosis. Sebaceous hyperplasia is characterized by a central umbilication—a small depression in the middle of the bump which represents the ductal opening. Under a dermoscope, clinicians look for specific markers such as the "cumulus sign" (asymmetrical milky-white structures) and the "bonbon toffee sign." The latter is a distinct visual cue where the central umbilication is surrounded by accumulated sebum.

Another critical feature is the presence of "crown vessels"—fine, non-arborizing blood vessels that wrap around the periphery of the lesion but do not cross the center. Differentiating these from the disorganized, telangiectatic vessels of basal cell carcinoma (BCC) is the most vital step before any destructive treatment is initiated. If a lesion shows irregular growth or bleeds easily, a biopsy remains the gold standard to rule out malignancy.

Modern Procedural Treatments

High-Frequency Focused Ultrasound (HIFU)

One of the most significant advancements in the past year involves the use of high-frequency focused ultrasound, specifically at 20 MHz, for treating sebaceous hyperplasia. Unlike traditional HIFU used for skin lifting, this specialized frequency targets the superficial dermis where sebaceous glands reside.

Clinical data suggests that 20 MHz HIFU achieves a resolution rate of nearly 88% after a single session. The mechanism relies on both thermal and mechanical effects. Thermal energy exceeds 60°C at the focal point, causing coagulative necrosis of the enlarged sebocytes. Simultaneously, acoustic cavitation creates microbubbles that mechanically disrupt the glandular structure without damaging the overlying epidermis. This treatment is increasingly favored because it is virtually painless and carries a significantly lower risk of post-inflammatory hyperpigmentation compared to lasers.

Carbon Dioxide (CO2) Laser Ablation

The CO2 laser remains a cornerstone of sebaceous hyperplasia treatment due to its precision. It works by emitting a wavelength that is highly absorbed by water in the skin tissues, effectively vaporizing the enlarged gland. To prevent recurrence, the laser must reach the deeper portion of the sebaceous unit.

However, the trade-off for this efficacy is a longer recovery period. The treated area will typically form a small crust that takes 7 to 10 days to heal. There is a moderate risk of atrophic scarring (small pits) or hypopigmentation if the ablation depth is not meticulously controlled. Fractional CO2 settings are sometimes used to reduce these risks, though multiple sessions may be required for complete clearance.

Electrosurgery and Electrodesiccation

Electrodesiccation involves using a fine needle electrode to deliver an electric current directly into the umbilication of the lesion. This current thermally destroys the sebaceous lobules. It is a rapid, office-based procedure that is highly effective for isolated lesions. The primary challenge with electrosurgery is the lack of depth control compared to modern lasers; however, in the hands of an experienced clinician, it remains a cost-effective and reliable option. The resulting scab usually falls off within a week, leaving a temporary red mark that fades over time.

Photodynamic Therapy (PDT)

For patients with widespread, eruptive sebaceous hyperplasia, treating individual bumps one by one is often impractical. Photodynamic Therapy offers a field-treatment approach. A photosensitizing agent, such as 5-aminolevulinic acid (ALA), is applied to the skin and allowed to incubate for several hours. Because sebaceous glands are highly active, they preferentially absorb the ALA.

When the skin is subsequently exposed to a specific wavelength of blue or red light, a photochemical reaction occurs that selectively destroys the overactive glands. While effective for reducing the overall number and size of lesions across the entire face, PDT can cause significant redness, peeling, and sun sensitivity for several days post-treatment.

Pharmacological Approaches

Systemic Isotretinoin

Oral isotretinoin is perhaps the only treatment that addresses the underlying pathophysiology of sebaceous hyperplasia by shrinking the glands systemically. It is particularly useful for patients with dozens or hundreds of lesions that are resistant to physical destruction.

Lower doses (e.g., 10–20 mg every other day) are often employed to manage the condition with fewer side effects than the high doses used for cystic acne. While the response is often dramatic within 2 to 6 weeks, the primary drawback is the high rate of recurrence once the medication is discontinued. Some clinical protocols suggest a cumulative dose of 40–60 mg/kg may lead to more sustained clearance, but many patients require long-term low-dose maintenance therapy. Due to its systemic nature and potential side effects, isotretinoin requires regular blood monitoring and strict adherence to safety protocols.

Topical Options and Their Limitations

Topical retinoids (such as tretinoin or adapalene) are frequently prescribed but generally offer modest results for established hyperplasia. They are more effective as a preventive measure or as maintenance after a procedural treatment, as they help regulate skin cell turnover and prevent the ducts from becoming clogged.

Chemical peels using trichloroacetic acid (TCA) or bichloracetic acid can be used to chemically cauterize the bumps. While effective for flattening the lesions, the depth of penetration is harder to control than with lasers, which may lead to irregular skin texture if applied too aggressively.

Why Do These Bumps Keep Coming Back?

The fundamental challenge in sebaceous hyperplasia treatment is the biological drive of the gland. As we age, especially in men and post-menopausal women, androgen levels fluctuate. While circulating androgens may decrease, the sebocytes in the face become more sensitive to these hormones. This leads to a slower turnover of cells within the gland, causing them to back up and enlarge.

Because most physical treatments only destroy the visible portion of the gland, the remaining sebaceous germinative cells can eventually regenerate a new lesion. Permanent clearance usually requires the total destruction of the pilosebaceous unit, which inherently increases the risk of a visible scar. Therefore, the goal of treatment is often "management" rather than a permanent "cure."

Factors That Influence Treatment Success

  1. Skin Type: Patients with darker skin tones (Fitzpatrick types IV-VI) must be cautious with thermal treatments like CO2 lasers and electrosurgery due to the high risk of post-inflammatory hyperpigmentation. In these cases, HIFU or low-dose isotretinoin may be safer alternatives.
  2. Medication History: Individuals on long-term immunosuppressants, particularly Cyclosporine A, have a significantly higher prevalence of sebaceous hyperplasia. The drug has a stimulatory effect on undifferentiated sebocytes. For these patients, lesions are often more aggressive and resistant to standard topical therapies.
  3. Hormonal Environment: Conditions that increase insulin or thyroid-stimulating hormone (TSH) can exacerbate the proliferation of sebocytes. Managing underlying metabolic or endocrine issues may help slow the progression of new bumps.

Post-Treatment Care and Prevention

After any destructive procedure, the primary goal is to prevent infection and minimize scarring. Keeping the treated areas moist with a thin layer of petrolatum or a prescribed antibiotic ointment is standard practice. Avoiding direct sun exposure is mandatory, as the newly healing skin is highly susceptible to UV-induced pigment changes.

To prevent the formation of new lesions, a consistent skincare routine involving a gentle salicylic acid cleanser and a nightly retinoid is recommended. While these won't remove existing large bumps, they can keep the pores clear and potentially suppress the early stages of glandular overgrowth. Additionally, avoiding heavy, occlusive oils in moisturizers and sunscreens can prevent unnecessary irritation of the sebaceous ducts.

Choosing the Right Path

Selecting a treatment for sebaceous hyperplasia is a balance between cosmetic goals, budget, and tolerance for downtime.

  • For a few isolated bumps: Electrosurgery or CO2 laser is often the most direct and efficient route.
  • For widespread lesions with minimal downtime: HIFU (20 MHz) represents the cutting edge for those who want to avoid scabbing and redness.
  • For severe, eruptive cases: A combination of PDT and low-dose oral isotretinoin offers the best chance at long-term control.

It is important to maintain realistic expectations. Because sebaceous hyperplasia is a reflection of the skin's internal aging and hormonal process, new lesions may appear over time regardless of the treatment chosen. Regular follow-ups with a dermatology professional ensure that any new growths are monitored and that the skin remains healthy and clear of more serious conditions that mimic these benign yellow bumps.